MedTrace Logo

An EFS to Evaluate the CGuard Prime™ Carotid Stent in Acute Ischemic Stroke

NCT06447116 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2026-03-05

No results posted yet for this study

Summary

The Jacobs Institute is conducting a Sponsor Investigator study of patients ≥ 18 years to establish safety and preliminary effectiveness in treating extracranial stenosis with the CGuard Prime™ Carotid Stent in the setting as an acute ischemic stroke.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

CGuard Prime™ Carotid Stent System

CGuard Prime™ Carotid Stent System

Sponsors & Collaborators

  • Jacobs institute

    lead OTHER

Principal Investigators

  • CARLOS LOUIS PENA, PhD · Jacobs institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-12-31
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06447116 on ClinicalTrials.gov